In luminal B breast cancer, membrane receptors such as HER2, HER3, and EGFR (HER1) can reside and interact within cholesterol enriched domains, thus creating activated receptor platforms that support rapid signaling (Gueguinou et al., 2015; Marquez & Pietras, 2001). The gene discussed is EGFR; the disease is breast carcinoma.